Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 172
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00176488 | Epirubicin and Vinorelbine in Treating Patients With Stage II, Stage III, or Stage IV Breast Cancer | ||
| NCT02620527 | Concordance Between ctDNA Assay and FoundationOne | ||
| NCT03112668 | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners | ||
| NCT05785780 | Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings | ||
| NCT00323791 | Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer | ||
| NCT00156299 | Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate | ||
| NCT00003365 | Sulindac and Plant Compounds in Preventing Colon Cancer | ||
| NCT01018836 | Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases | ||
| NCT01407562 | Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors | ||
| NCT03061175 | Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy | ||
| NCT00728845 | Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer | ||
| NCT00899808 | Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer | ||
| NCT02400190 | The IDEA Study (Individualized Decisions for Endocrine Therapy Alone) | ||
| NCT03102060 | Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant | ||
| NCT01694589 | A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer | ||
| NCT00866840 | Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery | ||
| NCT04839588 | Telerehabilitation Cognitive Impairments Following Chemotherapy Usability Study | ||
| NCT03902379 | Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer | ||
| NCT04294264 | TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer | ||
| NCT00118053 | Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer | ||
| NCT00176501 | Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | ||
| NCT01828476 | Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer | ||
| NCT04211259 | Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization | ||
| NCT00176605 | Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer | ||
| NCT00323362 | Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer | ||
| NCT00496366 | Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer | ||
| NCT04163952 | Talimogene Laherparepvec and Panitumumab for the Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Skin | ||
| NCT02203578 | Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease | ||
| NCT03229278 | Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma | ||
| NCT02117817 | Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer | ||
| NCT00634634 | Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer | ||
| NCT04829383 | A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma | ||
| NCT07348679 | Cigarette Filter Study | ||
| NCT03272633 | Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies | ||
| NCT02526498 | Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery | ||
| NCT00118131 | Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00770055 | Internet Use Among Women With Recurrent Metastatic Breast Cancer | ||
| NCT02885649 | Enzalutamide Before Surgery in Treating Patients With Kidney Cancer | ||
| NCT01711944 | Online Problem Solving Skills Training | ||
| NCT02250781 | Oral ONC201 in Treating Patients With Advanced Solid Tumors | ||
| NCT02421575 | Hydroxychloroquine in Blocking Autophagy in Patients With Prostate Cancer Undergoing Surgery or Active Surveillance | ||
| NCT02526511 | Perfusion Magnetic Resonance Imaging in Diagnosing Patients With Kidney Tumors | ||
| NCT01617161 | Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer | ||
| NCT00161213 | Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer | ||
| NCT05400941 | Aim 3, Adapting and Implementing Evidence-based Breast Cancer Follow-up in Primary Care | ||
| NCT00776594 | Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy | ||
| NCT00905918 | Vitamin E Supplements in Treating Patients Undergoing Surgery for Colorectal Cancer | ||
| NCT02203604 | High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery | ||
| NCT02748564 | Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma | ||
| NCT03108911 | Gluten Free Diet in Diminishing Side Effects Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy |
